Published in Diabetologia on July 04, 2006
Diet and Medical Therapy Versus Bariatric Surgery in Type 2 Diabetes (DIBASY) | NCT00888836
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15
The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab (2008) 2.27
Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology (2013) 1.55
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45
Current status of islet cell replacement and regeneration therapy. J Clin Endocrinol Metab (2010) 1.43
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care (2009) 1.41
Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab (2010) 1.00
Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab (2014) 0.99
Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2). J Obes (2012) 0.91
Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance. PLoS One (2013) 0.88
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol (2014) 0.85
Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents. Diabetes Technol Ther (2010) 0.83
Comparison of Bariatric Surgical Procedures for Diabetes Remission: Efficacy and Mechanisms. Diabetes Spectr (2012) 0.82
β-Cell function improvements in grade I/II obese subjects with type 2 diabetes 1 month after biliopancreatic diversion: results from modeling analyses of oral glucose tolerance tests and hyperglycemic clamp studies. Diabetes Care (2013) 0.79
Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus. World J Gastroenterol (2014) 0.78
The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index < 35 kg/m(2): preliminary results. Ann Surg Treat Res (2015) 0.75
Bariatric surgery in morbidly obese insulin resistant humans normalises insulin signalling but not insulin-stimulated glucose disposal. PLoS One (2015) 0.75
Prevention and current onset delay approaches of type 2 diabetes mellitus (T2DM). Eur J Clin Pharmacol (2011) 0.75
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care (1991) 9.95
Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56
Effect of fatty acids on glucose production and utilization in man. J Clin Invest (1983) 4.00
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia (2005) 3.97
Insulin resistance in essential hypertension. N Engl J Med (1987) 3.78
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest (1997) 3.66
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest (1989) 3.03
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia (2003) 2.80
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1982) 2.48
Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes (1983) 2.45
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism (1989) 2.27
Effect of insulin on uric acid excretion in humans. Am J Physiol (1995) 2.25
Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A (1978) 2.08
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab (1997) 2.04
The disposal of an oral glucose load in healthy subjects. A quantitative study. Diabetes (1985) 1.88
Splanchnic and peripheral disposal of oral glucose in man. Diabetes (1983) 1.82
Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab (2013) 1.82
Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology (1998) 1.79
Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes (1987) 1.76
Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism (1987) 1.76
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. Diabetes Obes Metab (2010) 1.76
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Coronary hemodynamics and myocardial metabolism in patients with syndrome X: response to pacing stress. J Am Coll Cardiol (1991) 1.68
Reference values for respiratory rate in the first 3 years of life. Pediatrics (1994) 1.65
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects. Diabetologia (2005) 1.61
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes (1992) 1.60
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study. J Clin Endocrinol Metab (2004) 1.59
Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest (1981) 1.59
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. Am J Med (1983) 1.59
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes (2000) 1.57
The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1991) 1.57
Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care (2001) 1.56
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia (2000) 1.54
The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab (2011) 1.53
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. Circulation (1997) 1.53
Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion. Diabetologia (2013) 1.51
Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia (2008) 1.51
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia (2008) 1.50
Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest (1985) 1.49
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review. Diabetologia (2006) 1.48
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol (1983) 1.43
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Dicarboxylic acids and glucose utilization in humans: effect of sebacate. JPEN J Parenter Enteral Nutr (1994) 1.40
Operation of Randle's cycle in patients with NIDDM. Diabetes (1990) 1.40
Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur J Gastroenterol Hepatol (2000) 1.39
Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia (2011) 1.38
Substrate supply as determinant of O2 extraction in sepsis and nonseptic trauma. Nutrition (1993) 1.38
Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens (1996) 1.38
Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev (1987) 1.37
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
An 18-year-old woman with familial chylomicronaemia who would not stick to a diet. Lancet (1996) 1.37
Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. Arch Dermatol (1998) 1.36
Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J Clin Endocrinol Metab (2001) 1.34
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. Am J Physiol (1980) 1.32
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production. Diabetes (1994) 1.29
Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol (1987) 1.28
Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension (1992) 1.27
Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism (2000) 1.27
Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes (Lond) (2010) 1.26
Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes (2001) 1.24
Insulin resistance in diabetic ketoacidosis. Diabetes (1982) 1.23
Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation (2001) 1.23
Effects of insulin on hemodynamics and metabolism in human forearm. Diabetes (1990) 1.20
Time dependence of the interaction between lipid and glucose in humans. Am J Physiol (1989) 1.19
Efficacy and safety of ipragliflozin in patients with type 2 diabetes inadequately controlled on metformin: a dose-finding study. Diabetes Obes Metab (2012) 1.16
Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med (2012) 1.14
Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes (Lond) (2009) 1.14
Spontaneous appendicocutaneous fistula: case report and literature review. Dis Colon Rectum (1981) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis (1989) 1.13
Glucose transport in human skeletal muscle. The in vivo response to insulin. Diabetes (1993) 1.12
Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2006) 1.12
Kinetic analysis of plasma insulin disappearance in nonketotic diabetic patients and in normal subjects. A tracer study with 125I-insulin. J Clin Invest (1978) 1.11
Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues. J Med Chem (1987) 1.10
Clinical and functional results after restorative proctocolectomy. Br J Surg (1988) 1.10
Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest (1996) 1.10
Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am J Physiol Endocrinol Metab (2000) 1.07
Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans. Circulation (2000) 1.07
Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab (2004) 1.06
Insulin action and substrate competition. Baillieres Clin Endocrinol Metab (1993) 1.05
Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes (1988) 1.05
Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes. Clin Pharmacol Ther (2007) 1.05
Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea. Horm Metab Res (2006) 1.05
The kinetics of insulin in man. II. Role of the liver. Diabetes Metab Rev (1987) 1.04
Splanchnic and leg substrate exchange after ingestion of a natural mixed meal in humans. Diabetes (1999) 1.04